Angiosarcomas are rare tumors that predominantly affect adults. Hepatic angiosarcoma in a child is an extremely rare event and is associated with a poor prognosis. Herein, we report our experience in a case of hepatic angiosarcoma in a child who presented with a huge unresectable mass that underwent liver transplantation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jpedsurg.2010.09.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ultrasonography, contrast-enhanced ultrasonography and contrast-enhanced computer tomography features of hepatic sarcomatoid carcinoma and hepatic sarcoma: a retrospective study of 23 cases.
BMC Cancer
January 2025
Department of Ultrasonography, Nanjing Drum Tower Hospital, Drum Tower Clinical Medical College, Nanjing Medical University, Nanjing, 21009, China.
Background: Hepatic sarcomatoid carcinoma (HSC) and hepatic sarcoma (HS) are rare malignancies. Without pathology, the differential diagnosis between these two tumors is difficult due to their frequent overlaps in clinical presentations and imaging features. Currently, there are limited analyses about the ultrasound (US), contrast-enhanced ultrasound (CEUS) and contrast-enhanced computer tomography (CECT) characteristics of HSC and HS.
View Article and Find Full Text PDFDemographics, Prognostic Factors, and Survival Outcomes in Hepatic Angiosarcoma: A Retrospective Analysis.
J Gastrointest Cancer
December 2024
Department of Pathology, Texas Tech University Health Sciences Center, 3601 4Th ST, Lubbock, TX, USA.
Article Synopsis
- Hepatic angiosarcoma (HA) is a rare cancer with no standardized treatment protocols; a study aims to analyze clinicopathologic data, prognostic factors, and treatment outcomes.
- From 2000 to 2021, data from 389 HA patients showed a low overall 3-year survival rate of only 6.7%, with surgical resection offering the best outcome at a 1-year survival rate of 18.20%.
- Key negative prognostic factors included age over 70, male sex, and distant tumor stage, while female sex appeared to be a positive factor, suggesting a need for improved management strategies.
An acute progressing hepatic angiosarcoma in a young male diagnosed by contrast-enhanced ultrasound-guided liver needle biopsy: a case report.
Transl Gastroenterol Hepatol
September 2024
Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Background: Primary hepatic angiosarcoma (PHA) is a rare hepatic malignancy primarily observed in the elderly. It carries a poor prognosis as a result of the characteristics of rapid progression, high aggressiveness, and resistance to traditional chemo- and radiotherapies. Its nonspecific clinical manifestations, along with the lack of laboratory features and various imaging findings, make it hard to recognize in clinic, especially among non-high-risk populations.
View Article and Find Full Text PDFPrimary sinusoidal-type hepatic angiosarcoma presenting with acute liver failure.
Dig Liver Dis
December 2024
Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
An Infiltrative Case of Angiosarcoma Causing Portal Hypertension.
ACG Case Rep J
October 2024
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN.
Hepatic angiosarcoma is a rare and aggressive liver tumor. We report a case study of an 82-year-old elderly gentleman who presented with failure to thrive and ascites. Initially suspected to be cirrhosis, biopsy results eventually concluded angiosarcoma of the liver.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!